Clinical trial
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or…
NCT00276003 · University of New Mexico, Other · Completed
Key facts
| NCT number | NCT00276003 |
|---|---|
| Title | INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma. |
| Official title | INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma. |
| Lead sponsor | University of New Mexico, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma, Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine, Irinotecan, Allopurinol. |
| Enrollment | 22 |
| Start date | Aug 1, 2002 |
| Primary completion | Jun 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Jan 12, 2006 |
| Last update posted | Jan 7, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: